Oya Yonal
Overview
Explore the profile of Oya Yonal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
521
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yonal O, Eren F, Yilmaz Y, Atug O, Over H
Turk J Gastroenterol
. 2015 Jan;
25(6):639-43.
PMID: 25599774
Background/aims: The endocannabinoid system can exert beneficial effects on gastrointestinal inflammation, and cannabinoid receptor-2 (CB2) agonists may represent a new therapeutic approach in inflammatory bowel disease (IBD). A functional CB2...
2.
Yonal O, Ibrisim D, Songur Y, Cakaloglu Y, Tuncer K, Kirimlioglu H, et al.
Case Rep Gastroenterol
. 2013 Jul;
7(2):272-6.
PMID: 23898233
Primary malignant melanoma of the esophagus (PMME) comprises only 0.1-0.2% of all malignant esophageal tumors. PMME tumors are highly aggressive and metastasize early via hematogenic and lymphatic pathways. Treatment outcome...
3.
Yonal O, Hatemi G, Hamzaoglu O
Turk J Gastroenterol
. 2013 Apr;
23 Suppl 2:25-9.
PMID: 23576087
No abstract available.
4.
Yonal O, Hatemi G, Kaymakoglu S
Turk J Gastroenterol
. 2013 Apr;
23 Suppl 2:21-4.
PMID: 23576086
No abstract available.
5.
Yilmaz Y, Yonal O, Deyneli O, Ataizi Celikel C, Kalayci C, Duman D
Acta Gastroenterol Belg
. 2012 Aug;
75(2):240-4.
PMID: 22870790
Background & Aims: Preliminary evidence suggests that inhibition of dipeptidyl peptidase (DPP)-IV preserves pancreatic beta cell function in patients with type 2 diabetes (T2D). However, its effects on liver histology...
6.
Yilmaz Y, Yonal O, Kurt R, Bayrak M, Aktas B, Ozdogan O
Hepat Mon
. 2011 Nov;
11(2):103-6.
PMID: 22087126
Background: The aspartate aminotransferases (AST) to platelet ratio index (APRI) may serve as a noninvasive marker to assess liver fibrosis. Objectives: To assess the diagnostic ability of the APRI for...
7.
Yilmaz Y, Eren F, Yonal O, Polat Z, Bacha M, Kurt R, et al.
Dis Markers
. 2011 Nov;
31(4):205-10.
PMID: 22045426
Background: Elevated progranulin levels are associated with visceral obesity, elevated plasma glucose, and dyslipidemia. Progranulin has not been previously investigated as a biomarker of nonalcoholic fatty liver disease (NAFLD). We...
8.
Yilmaz Y, Eren F, Kurt R, Yonal O, Polat Z, Senates E, et al.
Clin Biochem
. 2011 Jun;
44(12):955-8.
PMID: 21635880
Objectives: Galectin-3 might serve as a biomarker of human metabolic alterations. We measured serum levels of galectin-3 in patients with nonalcoholic fatty liver disease (NAFLD) and examined their association with...
9.
Yilmaz Y, Kurt R, Gurdal A, Ozen Alahdab Y, Yonal O, Senates E, et al.
Atherosclerosis
. 2011 Apr;
217(1):125-9.
PMID: 21513939
Background: Patients with nonalcoholic fatty liver disease (NAFLD) have a reduced coronary flow reserve (CFR) and an increased risk of cardiovascular disease. The fat cells that surround coronary arteries may...
10.
Atasoy B, Yonal O, Demirel B, Dane F, Yilmaz Y, Kalayci C, et al.
Eur Arch Otorhinolaryngol
. 2011 Apr;
269(1):275-82.
PMID: 21472468
To investigate the impact of early insertion of percutaneous endoscopic gastrostomy-tube on nutritional status and completeness of concurrent chemotherapy in locally advanced head and neck cancer patients treated with chemoradiotherapy....